Abstract
Background
The number of recognised distinct autoimmune diseases (AIDs) has progressively increased over the years with more than 100 being reported today. The natural history of AIDs is characterized by progression from latent and subclinical to clinical stages and is associated with the presence of the specific circulating autoantibodies. Once presented, AIDs are generally chronic conditions. AIDs have the tendency to cluster and co-occur in a single patient. Autoimmune thyroid diseases (AITD) are the most prevalent of AIDs in the world population, and about one-third of the AITD patients also present with a non-thyroid AID during their life-span. Furthermore, patient with non-thyroid AIDs often presents with a form of AITD as a concurrent condition. Many of the clusters of AIDs are well characterized as distinctive syndromes, while some are infrequent and only described in case reports.
Purpose
In this review, we describe the wide spectrum of the combinations and the intricate relationships between AITD and the other AIDs, excluding Addison’s disease. These combinations are collectively termed type 3 Autoimmune Polyglandular Syndrome (APS-3), also called type 3 Multiple Autoimmune Syndrome (MAS-3), and represent the most frequent APS in the world populations.
Conclusions
Numerous associations of AITD with various AIDs could be viewed as if the other AIDs were gravitating like satellites around AITD located in the center of a progressively expanding galaxy of autoimmunity.
Similar content being viewed by others
References
Roitt IM, Doniach D, Campbell PN, Hudson RV (1956) Auto-antibodies in Hashimoto’s disease (lymphadenoid goitre). Lancet 271:820–821
Rose NR, Witebsky E (1956) Studies in organ specificity. V. Changes in the thyroid glands of rabbit following active immunization with rabbit thyroid extracts. J Immunol 76:417–427
Adams DD, Purves HD (1956) Abnormal responses in the assay of thyrotropin. Proc Univ Otago Med School 34:11–12
Kriss JP (1968) Inactivation of long-acting thyroid stimulator (LATS) by anti-kappa anti-lambda antisera. Clin Endocrinol 28:1440–1444
Witebsky E, Rose NR, Terplan K, Paine JR, Egan RW (1957) Chronic thyroiditis and autoimmunization. JAMA 164:1439–1447
The Autoimmune diseases (2020) Sixth Edition, Rose N, MacKay IR (eds.) Academic Press. St. Louis MO
Dayan CM, Daniels GH (1996) Chronic autoimmune thyroiditis. N Engl J Med 335:99–107
Ralli M, Angeletti D, Fiore M (2020) Hashimoto’s thyroiditis: an update on pathogenic mechanisms, diagnostic protocols, therapeutic strategies, and potential malignant transformation. Autoimmune Rev 19:102649
Weetman AP (2000) Graves’ disease. N Engl J Med 343:1236–1248
Smith TJ, Hegedüs L (2016) Graves’ disease. N Engl J Med 375:1552–1565
Neufeld M, Blizzard RM (1980) Polyglandular autoimmune diseases. In: Pinchera A, Doniach D, Fenzi GF, Baschieri L (eds) Symposium on autoimmune aspects of endocrine disorders. Academic Press, New York pp, pp 357–365
Ahonen P, Myllarniemi S, Sipila I, Perheentupa J (1990) Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med 322:1829–1836
Betterle C, Sabbadin C, Scaroni C, Presotto F (2019). Autoimmune Polyendocrine Syndromes (APS) or Multiple Autoimmune Syndromes (MAS). In: Colao A., Jaffrain-Rea ML, Beckers A (eds) Polyendocrine Disorders and Endocrine Neoplastic Syndromes. Endocrinology. Springer Nature Switzerland AG. https://doi.org/10.1007/978-3-319-73082-0_1-1
Betterle C, Presotto F, Furmaniak J (2019) Epidemiology, pathogenesis, and diagnosis of Addison’s disease in adults. J Endocrinol Invest 42:1407–1433
Beccuti G, Ghizzoni L, Cambria V et al (2020) A COVID-19 pneumonia case report of autoimmune polyendocrine syndrome type 1 in Lombardy, Italy: letter to the editor. J Endocrinol Invest 43:1175–1177
Garelli S, Dalla Costa M, Sabbadin C et al (2021) Autoimmune polyendocrine syndrome type 1: an Italian survey on 158 patients. J Endocrinol Invest 44:2493–2510
Schmidt MB (1926) Eine biglandulare Erkrankung (Nebennieren und Schilddrüse) bei Morbus Addisonii. Verh Dtsch Ges Pathol 21:212–221
Pham-Dobor G, Hanák L, Hegyi P et al (2020) Prevalence of other autoimmune diseases in polyglandular autoimmune syndromes type II and III. J Endocrinol Invest 43:1–9
Husebye ES, Anderson MS, Kampe O (2018) Autoimmune polyendocrine syndromes. NEJM 378:1132–1141
Rose NR (1997) Autoimmune diseases: tracing the shared threads. Hosp Pract (1995) 32:147–154
Humbert P, Dupond JL (1988) Les syndromes auto-immuns multiples (S.A.M.) [Multipleautoimmune syndromes]. Ann Med Interne (Paris) 139:159–168
Betterle C, Presotto F (2008) Autoimmune Polyendocrine Syndrome (APS) or Multiple autoimmune syndrome (MAS). In: Walker S, Jara LJ (eds) Handbook of systemic autoimmune diseases, endocrine manifestations of systemic autoimmune diseases. Elsevier, Amsterdam, pp 135–148
Anaya JM, Castiblanco J, Rojas-Villarraga A et al (2012) The multiple autoimmune syndromes. A clue for the autoimmune tautology. Clin Rev Allergy Immunol 43:256–264
Rojas-Villarraga A, Amaya-Amaya J, Rodriguez-Rodriguez A et al (2012) Introducing polyautoimmunity: secondary autoimmune diseases no longer exist. Autoimmune Dis. 254319
Bliddal S, Nielsen CH, Feldt-Rasmussen U (2017) Recent advances in understanding autoimmune thyroid disease: the tallest tree in the forest of polyautoimmunity. F1000 Res 6:1776
Betterle C, Callegari GP, Presotto F et al (1987) Thyroid autoantibodies: a good marker for the study of symptomless autoimmune thyroiditis. Acta Endocrinol (Copenaghen) 114:321–327
Prentice LM, Phillips DIW, Sarsero D, Beever K, McLachlan SM, Rees Smith B (1990) Geographical distribution of subclinical autoimmune thyroid disease in Britain: a study using highly sensitive direct assays for autoantibodies to thyroglobulin and thyroid peroxidase. Acta Endocrinol (Copenh) 123:493–498
Prummel MF, Wiersinga WM (2005) Thyroid peroxidase autoantibodies in euthyroid subjects. Best Pract Res Clin Endocrinol Metab 19:1–15
Vanderpump MP (2011) The epidemiology of thyroid disease. Br Med Bull 99:39–51
McLeod DS, Cooper DS (2012) The incidence and prevalence of thyroid autoimmunity. Endocrine 42:252–265
Canaris GJ, Manowitz NR, Mayor G, Ridgway EC (2000) The Colorado thyroid disease prevalence study. Arch Intern Med 160:526–534
Weetman AP (2005) Non-thyroid autoantibodies in autoimmune thyroid disease. Best Pract Res Clin Endocrinol Metab 19:17–32
Nakamura H, Usa T, Motomura M (2008) Prevalence of interrelated autoantibodies in thyroid diseases and autoimmune disorders. J Endocrinol Invest 31:861–865
Boelaert K, Newby PR, Simmonds MJ et al (2010) Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease. Am J Med 123:183.e1–9
Wiebolt J, Achterbergh R, den Boer A et al (2011) Clustering of additional autoimmunity behaves differently in Hashimoto’s patients compared with Graves’ patients. Eur J Endocrinol 164:789–794
Ruggeri RM, Imbesi S, Saitta S et al (2013) Chronic idiopathic urticaria and Graves’ disease. J Endocrinol Invest 36:531–536
Radetti G (2014) Clinical aspects of Hashimoto’s thyroiditis. Endocr Dev 26:158–170
Fallahi P, Ferrari SM, Ruffilli I et al (2016) The association of other autoimmune diseases in patients with autoimmune thyroiditis: review of the literature and report of a large series of patients. Autoimmun Rev 15:1125–1128
Ferrari SM, Fallahi P, Ruffilli I (2019) The association of other autoimmune diseases in patients with Graves’ disease (with or without ophthalmopathy): review of the literature and report of a large series. Autoimmun Rev 18:287–292
Rotondi M, Virili C, Pinto S et al (2020) The clinical phenotype of Graves’ disease occurring as an isolated condition or in association with other autoimmune diseases. J Endocrinol Invest 43:157–162
Guarnotta V, Pillitteri G, Gambino G et al (2021) Levothyroxine and insulin requirement in autoimmune polyglandular type 3 syndrome: a real-life study. J Endocrinol Invest 44:1387–1394
Bouça B, Nogueira A, Caetano J, Cardoso R, Dinis I, Mirante A (2022) Clinical characteristics of polyglandular autoimmune syndromes in pediatric age: an observational study. J Pediatr Endocrinol Metab 35:477–480
Acay A, Ulu MS, Ahsen A, Eroglu S, Ozuguz U, Yuksel S, Acarturk G (2014) Assessment of thyroid disorders and autoimmunity in patients with rheumatic diseases. Endocr Metab Immune Disord Drug Targets 14:182–186
Posselt RT, Coelho VN, Pigozzo DC et al (2017) Prevalence of thyroid autoantibodies in patients with systematic autoimmune rheumatic diseases. Cross-sectional study. Sao Paulo Med J 135:535–540
Fallahi P, Ferrari SM, Ruffilli I et al (2017) Increased incidence of autoimmune thyroid disorders in patients with psoriatic arthritis: a longitudinal follow-up study. Immunol Res 65:681–686
Fallahi P, Ruffilli I, Giuggioli D et al (2017) Associations between systemic sclerosis and thyroid diseases. Front Endocrinol (Lausanne) 8:266
Lahner E, Conti L, Cicone F et al (2020) Thyro-entero-gastric autoimmunity: pathophysiology and implications for patient management. Best Pract Res Clin Endocrinol Metab 34:101373
Kahaly GJ, Frommer L (2018) Polyglandular autoimmune syndromes. J Endocrinol Invest 41:91–98
Yanay H (2018) Autoimmune polyendocrine syndromes. NEJM 378:2542–2543
Atkinson MA, Eisenbarth GS (2001) Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 358:221–229
Guastamacchia E, Triggiani V, Aglialoro A et al (2015) Italian Association of Clinical Endocrinologists (AME) & Italian Association of Clinical Diabetologists (AMD) Position Statement: Diabetes mellitus and thyroid disorders: recommendations for clinical practice. Endocrine 49:339–352
Gambelunghe G, Forini F, Laureti S et al (2000) Increased risk for endocrine autoimmunity in Italian type 2 diabetic patients with GAD65 autoantibodies. Clin Endocrinol (Oxf) 52:565–573
Jenkins RC, Weetman AP (2002) Disease associations with autoimmune thyroid disease. Thyroid 12:977–988
Betterle C, Spadaccino AC, Presotto F et al (2002) The number of markers of pancreatic autoimmunity increases the risk for Type 1 diabetes mellitus (DM) in Italian and English patients with organ-specific autoimmune diseases (OSAD). Ann N Y Acad Sci 958:276–280
Hirata Y, Ishizu H, Ouchi N et al (1970) Insulin autoimmunity in a case of spontaneous hypoglycemia. J Jpn Diabetes Soc 13:312–320
Censi S, Mian C, Betterle C (2018) Insulin autoimmune syndrome: from diagnosis to clinical management. Ann Transl Med 6:335
Censi S, Albergoni MP, Gallo N, Plebani M, Boscaro M, Betterle C (2018) Insulin autoimmune syndrome (Hirata’s disease) in an Italian patient: a case report and review of the literature. Clin Chem Lab Med 56:889–895
Hoek A, Schoemaker J, Drehhage HA (1997) Premature ovarian failure and ovarian autoimmunity. Endocrine Rev 18:107–134
Anderson JR, Goudie RB, Gray K, Stuart-Smith DA (1968) Immunological features of idiopathic Addison’s disease: an antibody to cells producing steroid hormones. Clin Exp Immunol 3:107–117
De Moraes RM, Blizzard RM, Garcia-Bunuel GS (1972) Autoimmunity and ovarian failure. Am J Obstet Gynecol 112:693–703
Coulam CB (1983) The prevalence of autoimmune disorders among patients with primary ovarian failure. Am J Reprod Immunol 4:63–66
Alper MM, Garner PR, Seibel MM (1986) Premature ovarian failure, current concepts. J Reprod Med 31:699–708
Mignot MH, Schoemaker J, Kleingeld M, Ramanath Rao B, Drexhage HA (1989) Premature ovarian failure. The association with autoimmunity. Eur J Obs Gynecol Repr Biol 30:59–66
Betterle C, Rossi A, Dalla Pria S et al (1993) Premature ovarian failure: autoimmunity and natural history. Clin Endocrinol 39:35–43
Belvisi L, Bombelli F, Sironi L, Doldi N (1993) Organ-specific autoimmunity in patients with premature ovarian failure. J Endocrinol Invest 16:889–892
Szeliga A, Calik-Ksepka A, Maciejewska-Jeske M et al (2021) Autoimmune diseases in patients with premature ovarian insufficiency-our current state of knowledge. Int J Mol Sci 22:2594. https://doi.org/10.3390/ijms22052594
Jiang Q, Wu T, Zhang Y et al (2021) Case report: a rare case of coexisting of autoimmune polyglandular syndrome Type 3 and isolated gonadotropin-releasing hormone deficiency. Front Immunol 14(12):734685
Caturegli P, Newschaffer C, Olivi A, Pomper MG, Burger PC, Rose NR (2005) Autoimmune hypophysitis. Endocr Rev 26:599–614
Caturegli P, Iwama S (2013) From Japan with love: another tessera in the hypophysitis mosaic. Clin Endocrinol Metab 98:1865–1868
Iwama S, Arima H (2020) Anti-pituitary antibodies as a marker of autoimmunity in pituitary glands. Endocr J 67:1077–1083
Kobayashi I, Inukai T, Takahashi M et al (1988) Anterior pituitary cell antibodies detected in Hashimoto’s thyroiditis and Graves’ disease. Endocrinol Jpn 35:705–708
Hansen BL, Hegedus L, Hansen GN, Hagen C, Hansen JM, Hoier-Madsen M (1989) Pituitary-cell autoantibody diversity in sera from patients with untreated Graves’ disease. Autoimmunity 5:49–57
Yabe S, Kanda T, Hirokawa M et al (1998) Determination of anti-pituitary antibody in patients with endocrine disorders by enzyme-linked immunosorbent assay and Western blot analysys. J Lab Clin Med 132:25–31
Nishino M, Yabe S, Murakami M, Kanda T, Kobayashi I (2001) Detection of antipituitary antibodies in patients with autoimmune thyroid disease. Endocrine J 48:185–191
De Bellis A, Bizzarro A, Conte M et al (2003) Antipituitary antibodies in adults with apparently idiopathic growth hormone deficiency and in adults with endocrine disorders. J Clin Endocrinol Metab 88:650–654
Nakahara R, Tsunekaua K, Yabe S et al (2005) Association of antipituitary antibodies and type 2 iodothyronine deiodase antibody in patients with autoimmune thyroid diseases. Endocr J 52:691–699
Manetti L, Lupi I, Morselli LL et al (2007) Prevalence functional significance of antipituitary antibodies in patients with autoimmune and non-autoimmune thyroid diseases. J Clin Endocrinol Metab 92:2176–2181
Schebaum WA, Bottazzo GF (1983) Autoantibodies to vasopressin cells in idiopathic diabetes insipidus: evidence for an autoimmune variant. Lancet 1:897–890
De Bellis A, Bizzarro A, Paglionico V et al (1994) Detection of vasopressin cell antibodies in some patients with autoimmune endocrine diseases without overt diabetes insipidus. Clin Endocrinol 40:173–177
Maghnie M, Ghirardello S, De Bellis A et al (2006) Idiopathic central diabetes insipidus in children and young adults is commonly associated with vasopressin-cell antibodies and markers of autoimmunity. Clin Endocrinol 65:470–478
Krysiak R, Samborek M (2011) Coexistence of autoimmune polyglandular syndrome type 2 and diabetes insipidus in pregnancy. Am J Med Sci 342:433–434
Goswami R, Marwaha RK, Goswami D et al (2006) Prevalence of thyroid autoimmunity in sporadic idiopathic hypoparathyroidism in comparison to type 1 diabetes and premature ovarian failure. J Clin Endocrinol Metab 91:4256–4259
Centanni M, Marignani M, Gargano L et al (1999) Atrophic body gastritis in patients with autoimmune thyroid disease. Arch Intern Med 159:1726–1730
Segni M, Borrelli O, Pucarelli I, Delle Fave G, Pasquino AM, Annibale B (2004) Early manifestations of gastric autoimmunity in patients with juvenile autoimmune thyroid diseases. J Clin Endocrinol Metab 69:4944–4948
Utiyama SRR, De Bem RS, Skare TL et al (2018) Anti-parietal cell antibodies in patients with autoimmune thyroid diseases. J Endocrinol Invest 41:523–529
Toh BH (2014) Diagnosis and classification of autoimmune gastritis. Autoimmun Rev 13:459–462
Cellini M, Santaguida MG, Virili C et al (2017) Hashimoto’s thyroiditis and autoimmune gastritis. Front Endocrinol (Lausanne) 8:92
Irvine WJ, Davies SH, Teitelbaum S, Delamore IW, Williams AW (1965) The clinical and pathological significance of gastric parietal cell antibody. Ann N Y Acad Sci 124:657–691
Ardeman S, Chanarin I, Krafchik B, Singer W (1966) Addisonian pernicious anemia and intrinsic factor antibodies in thyroid disorders. Quart J Med 35:421–431
Wangel AG, Schiller KF (1966) Diagnostic significance of antibody to intrinsic factor. Brit Med J 1:1274–1276
Schiller KF, Snyder M, Vallaron MB (1967) Gastric, haematological and immunological abnormalities in Hashimoto’s thyroiditis. Gut 8:582–587
Irvine WJ (1975) The association of atrophic gastritis with autoimmune thyroid diseases. J Clin Endocrinol Metab 4:351–377
Carmel R, Spencer A (1982) Clinical and subclinical thyroid diosrders associated with pernicious anemia. Arch Intern Med 142:1465–1469
Ness-Abramof R, Nabriski DA, Braverman LE et al (2006) Prevalence and evaluation of B12 deficiency in patients with autoimmune thyroid disease. Am J Med Sci 332:119–122
Velarde-Mayol C, de la Hoz-García B, del Cañizo-Fernández-Roldán C, Hernández-López AM, Loza-Candia I, Cardona-Hernández A (2015) Anemia perniciosa y enfermedades tiroideas autoinmunes en una población mayor de 65 años [Pernicious anemia and autoimmune thyroid diseases in elderly people]. Rev Esp Geriatr Gerontol 50:126–128
Zulfiqar AA, Andres E (2017) Association pernicious anemia and autoimmune polyendocrinopathy: a retrospective study. J Med Life 10:250–253
Green PHR, Cellier C (2007) Celiac disease. N Engl J Med 357:1731–1743
Lankaster-Smith MJ, Perrin J, Swarbrick ET, Wright JT (1974) Coeliac diseases and autoimmunity. Postgrad Med J 50:45–48
Cooper BT, Holmes GK, Cooke WT (1978) Coeliac disease and immunological disorders. BMJ 1:537–539
Hovdenak N (1986) Coliakiassosierte sykdommer. Tidsskr Nor Laegeforen 106:2143–2145
Biemond I, Pena AS, Groenland F, Mulder CJ, Tytgat GN (1987) Coeliac disease in the Netherlands: demographic data of a patient survey among the members of the Dutch coeliac society. Neth J Med 31:263–268
Midhagen G, Jarnerot G, Kraaz W (1988) Adult coeliac disease within a defined geographical area in Sweden. A study of prevalence and associated diseases. Scand J Gastroenterol 23:1000–1004
Snook JA, de Silva HJ, Jewell DP (1989) The association of autoimmune disorders with inflammatory bowel disease. Quart J Med 269:835–840
Collin P, Salmi J, Hällstrom O, Reunala T, Pasternack A (1994) Autoimmune thyroid disorders and coeliac disease. Eur J Endocrinol 130:137–140
Reunala T, Collin P (1997) Diseases associated with dermatitis herpetiformis. Br J Dermatol 136:315–318
Bottaro G, Cataldo F, Rotolo N, Spina M, Corazza GR (1999) The clinical pattern of subclinical/silent celiac disease: an anlysis on 1026 consecutive cases. Am J Gastroenterol 94:691–696
Counsell CE, Taha A, Ruddell WS (1994) Coeliac disease and autoimmune thyroid disease. Gut 35:844–846
Volta U, De Franceschi L, Molinaro N, Tetta C, Bianchi FB (1997) Organ-specific autoantibodies in coeliac disease: do they represent an epiphenomenon or the expression of associated autoimmune disorders? Ital J Gastroenterol Hepatol 1997:18–21
Sategna-Guidetti C, BrunoMazza M et al (1998) Autoimmune thyroid disease and coeliac disease. Eur J Gastroenterol Hepatol 10:927–931
Velluzzi F, Caradonna A, Boy MF et al (1998) Thyroid and coeliac disease; clinical, serological, and echographic study. Am J Gastroenterol 93:976–979
Toscano V, ContiAnastasi FG et al (2000) Importance of gluten in the induction of endocrine autoantibodies and organ dysfunction in adolescent celiac patients. Am J Gastroenterol 95:1742–1748
Ventura A, Neri E, Ughi C, Leopardi A, Citta A, Not T (2000) Gluten-dependent DM-related and thyroid-related autoantibodies in patients with coeliac disease. J Pediatr 137:263–265
Sategna-Guidetti C, Volta U, Ciacci C (2001) Prevalence of thyroid disorders in untreated adult coeliac disease patients and the effect of gluten withdrawall: an Italian multicenter study. Am J Gastroenterol 96:751–757
Hakanen M, Luotola K, Salmi J, Laippala P, Kaukinen K, Collin P (2001) Clinical and subclinical autoimmune thyroid disease in adult celiac disease. Dig Dis Sci 46:2631–2635
da Rosa Utiyama SR, da Silva Kotze LM, Nisihara RM et al (2001) Spectrum of autoantibodies in celiac patients and relatives. Dig Dis Sci 46:2624–2630
Ansaldi N, Palmas T, Corrias A et al (2003) Autoimmune thyroid diseases and celiac disease in children. J Pediatr Gastroenterol Nutr 37:63–66
Selimoglu MA, Ertekin V (2005) Autoimmune thyroid disease in children with celiac disease. J Pediatr Gastroenterol Nutr 40:611
Guariso G, Conte S, Presotto F et al (2007) Clinical, subclinical and potential autoimmune diseases in an Italian population of children with celiac disease. Aliment Pharmacol Ther 26:1409–1417
Meloni A, Mandas C, Jores RD, Congia M (2009) Prevalence of autoimmune thyroiditis in children with celiac disease and effect of gluten withdrawal. J Pediatr 155:51–5.5e1
Elfström P, Montgomery SM, Kämpe O, Ekbom A, Ludvigsson JF (2008) Risk of thyroid disease in individuals with celiac disease. J Clin Endocrinol Metab 93:3915–3921
Cuoco L, Certo M, Jorizzo RA et al (1999) Prevalence and early diagnosis of coeliac disease in autoimmune thyroid disorders. Ital J Gastroenterol Hepatol 31:283–287
Carroccio A, Custro N, Montaldo G, Giannitrapi L, Soresi M, Notarbartolo A (1999) Evidence of transient IgA anti-endomysial antibody positivity in a patient with Graves’ disease. Digestion 60:86–88
Valentino R, Savastano S, Tommaselli AP et al (1999) Prevalence of coeliac disease in patients with thyroid autoimmunity. Horm Res 51:124–127
Berti I, Trevisiol C, Tommasini A et al (2000) Usefulness of screening program for celiac disease in autoimmune thyroiditis. Dig Dis Sci 45:403–406
Kumar V, Rajadhyaksha M, Wortsman J (2001) Celiac disease-associated autoimmune endocrinopathies. Clin Diagn Lab Immunol 8:678–685
Meloni GF, Tomasi PA, Bertoncelli A, Fanciulli G, Delitala G, Meloni T (2001) Prevalence of silent celiac disease in patients with autoimmune thyroiditis from Northern Sardinia. J Endocrinol Invest 24:298–302
Volta U, Ravaglia G, Granito A et al (2001) Coeliac disease in patients with autoimmune thyroiditis. Digestion 64:161–165
Larizza D, Calcaterra V, De Giacomo C et al (2001) Celiac disease in children with autoimmune thyroid disease. J Pediatr 139:738–740
Fanciulli G, Tomasi PA, Caucci F, Lai E, Sanciu F, Delitala G (2005) Screening for celiac disease in patients with autoimmune thyroid disease: from research studies to daily clinical practice. Ann Ital Med Int 20:39–44
Sari S, Yesilkaya E, Egritas O, Bideci A, Dalgic B (2009) Prevalence of celiac disease in Turkish children with autoimmune thyroiditis. Dig Dis Sci 54:830–832
Spadaccino AC, Basso D, Chiarelli S et al (2008) Celiac disease in North Italian patients with autoimmune thyroid diseases. Autoimmunity 41:116–121
Roy A, Laszkowska M, Sundström J et al (2016) Prevalence of celiac disease in patients with autoimmune thyroid disease: a meta-analysis. Thyroid 26:880–890
Monsén U, Sorstad J, Hellers G, Johansson C (1990) Extracolonic diagnoses in ulcertive colitis: an epidemiological study. Am J Gastroenterol 85:711–716
Nishimura M, Yamamoto T, Iijima H, Moriwaki Y, Takahashi S, Hada T (2001) Basedow’s disease and chronic ulcerative colitis: a case report and review of the Japanese literature. Intern Med 40:44–47
Inokuchi T, Moriwaki Y, Takahashi S, Tsutsumi Z, Ka T, Yamamoto T (2005) Autoimmune thyroid disease (Graves’ disease and Hashimoto’s thyroiditis) in two patients with Crohn’s disease: case report and literature review. Inter Med 44:303–306
Bianchi GP, Marchesini G, Gueli C, Zoli M (1995) Thyroid involvement in patients with active inflammatory bowel diseases. Ital J Gastroenterol 27:291–295
Krawitt EL (2006) Autoimmune hepatitis. N Engl J Med 354:54–66
Piantanida E, Ippolito S, Gallo D et al (2020) The interplay between thyroid and liver: implications for clinical practice. J Endocrinol Invest 43:885–899
Cindoruk M, Yetkin I, Karakan T, Kandilci U (2002) The prevalence of autoimmune hepatitis in Hashimoto’s thyroiditis in a Turkish population. Acta Gastroenterol Belg 65:143–145
Zeniya M (1999) Thyroid disease in autoimmune liver diseases. Nippon Rinsho 57:1882–1887
Choudhuri G, Somani SK, Baba CS, Alexander G (2005) Autoimmune hepatitis in India: profile of an uncommon disease. Bio Med Central Gastroenterol 5:27. https://doi.org/10.1186/1471-230X-5-27
Khoury T, Kadah A, Mari A, Sbeit W, Drori A, Mahamid M (2020) Thyroid dysfunction is prevalent in autoimmune hepatitis: a case control study. Isr Med Assoc J 22:100–103
Zeng Q, Zhao L, Wang C et al (2020) Relationship between autoimmune liver disease and autoimmune thyroid disease: a cross-sectional study. Scand J Gastroenterol 55:216–221
Kaplan MM, Gerswin ME (2005) Primary biliary cirrhosis. N Engl J Med 353:1261–1273
Vallas M, Monier JC, Tourniaire J et al (1994) Prevalence of antimitochondrial antibodies in women with Hashimoto’s thyroiditis. Presse Med 23:1117–1120
Gaches F, Delaire L, Nadalon S, Loustaud-Ratti V, Vidal E (1998) Frèquence des maladies auto-immunes chez 218 patients atteints de pathologies thyroidienne auto-immunes. Rev Mèd Interne 19:173–179
Zukowski TH, Jorgensen RA, Dickson ER, Lindor KD (1998) Autoimmune conditions associated with primary biliary cirrhosis: response to ursodeoxycholic therapy. Am J Gastroenterol 93:958–961
Silveira MG, Mendes FD, Diehl NN, Enders FT, Lindor KD (2009) Thyroid dysfunctionin primary biliary cirrhosis, primary sclerosing cholangitis and non-alcoholicfatty liver disease. Liver Int 29:1094–1100
Crowe JP, Christensen E, Butler J et al (1980) Primary biliary cirrhosis: the prevalence of hypothyroidism and its relationship to thyroid autoantibodies and sicca syndrome. Gastroenterol 78:1437–1441
Elta GH, Sepersky RA, Goldberg MJ, Connors CM, Miller KB, Kaplan MM (1983) Increased incidence of hypothyroidism in primary biliary cirrhosis. Dig Dis Sci 28:971–975
Floreani AR, Mangini C, Reig A et al (2017) Thyroid dysfunction in primary biliary cholangitis: a comparative study at Two European Centers. Am J Gastroenterol 112:114–119
Efe C, Torgutalp M, Henriksson I et al (2021) Extrahepatic autoimmune diseases in primary biliary cholangitis: prevalence and significance for clinical presentation and disease outcome. J Gastroenterol Hepatol 36:936–942
Maggs JR, Chapman RW (2007) Sclerosing cholangitis. Curr Opin Gastroenterol 23:310–316
Saarinen S, Olerup O, Broomé U (2000) Increased frequency of autoimmune diseases in patients with primary sclerosing cholangitis. Am J Gastroenterol 95:3195–3199
Kamisawa T, Funata N, Hayashi Y et al (2003) A new clinicopathological Shimizuguchi R et al. Hypothyroidism in autoimmune pancreatitis entity of IgG4-related autoimmune disease. J Gastroenterol 38:982–984
Komatsu K, Hamano H, Ochi Y et al (2005) High prevalence of hypothyroidism in patients with autoimmune pancreatitis. Dig Dis Sci 50:1052–1057
Sah RP, Chari ST (2010) Clinical hypothyroidism in autoimmune pancreatitis. Pancreas 39:1114–1116
Shimizuguchi R, Kamisawa T, Endo Y et al (2018) Hypothyroidism in patients with autoimmune pancreatitis. World J Gastrointest Pharmacol Ther 9:16–21
Allison JR, Curtis AC (1955) Vitiligo and pernicious anemia. Arch Dermatol 72:407–408
Ochi Y, De Groot LJ (1969) Vitiligo in Graves’ disease. Ann Int Med 71:935–940
Miklaszewka M (1972) Clinical and immunologic aspects of the relation of acquired leukoderma (vitiligo) to thyroid diseases. Arch Immunol Ther Exp (Warsz) 20:885–892
Lerner AB (1959) Vitiligo. J Invest Dermatol 32:285–310
Cunliffe WJ, Hall R, Newell DJ, Stevenson CJ (1968) Vitiligo, thyroid diseases and autoimmunity. Brit J Dermatol 80:138–213
Brostoff J, Bor S, Feiwel M (1969) Autoantibodies in patients with vitiligo. Lancet 2:177–178
Peracchi M, Cavagnini F, Ghislanzoni G (1971) Anticorpi anti-tiroidei e malattie autoimmuni in pazienti con vitiligine. Giorn Ital Dermatol 46:487–491
Howitz J, Rehfeld JF (1974) Serum-gastrin in vitiligo. Lancet 1(7862):831–833
Bleehen SS (1972) Treatment of vitiligo with oral 4,5’,8-trimethylpsoralen (Trisolaren). Br J Dermatol 86:54–60
Howitz J, Schawartz M (1971) Vitiligo, achlorhydria, and pernicious anemia. Lancet 1:1131–1135
Woolfson H, Finn OA, Mackie RM, McQueen A, MacSween NM (1975) Serum anti-tumour antibodies and autoantibodies in vitiligo. Brit J Dermatol 92:395–400
Betterle C, Del Prete GF, Peserico A et al (1976) Autoantibodies in vitiligo. Arch Dermatol 112:1326
Grimes EP, Halder RM, Jones C et al (1983) Autoantibodies and their clinical significance in a black vitiligo population. Arch Dermatol 119:300–303
Betterle C, Caretto A, De Zio A et al (1985) Incidence and significance of organ-specific autoimmune disorders (clinical, latent or only autoantibodies) in patients with vitiligo. Dermatologica 171:419–423
Shong YK, Kim JA (1991) Vitiligo in autoimmune thyroid diseases. Thyroidology 3:89–91
Hann SK, Im S, Il Kim H, Kim HS, Lee YJ, Park YK (1993) Increased incidence of antismooth muscle antibody in Korean vitiligo patients. J Dermatol 20:679–683
Hegedus L, Heidenheim M, Gervil M, Hjalgrim H, Hoier-Madsen M (1994) High frequency of thyroid dysfunction in patients with vitiligo. Acta Derm Venereol (Stockh) 74:120–123
Schallreuter KU, Lemke R, Brandt et al (1994) Vitiligo and other diseases: coexistence or true association? Hamburg study on 321 patients. Dermatology 188:269–275
Kurtev A, Dourmishev AL (2005) Thyroid function and autoimmunity in children and adolescent with Vitiligo. Eur Acad Dermatol Venereol JEADV 18:109–111
Kroon MW, Vrijman C, Chandeck C et al (2013) High prevalence of autoimmune thyroiditis in children and adolescents with vitiligo. Horm Res Paediatr 79:137–144
Fan KC, Yang TH, Huang YC (2018) Vitiligo and thyroid disease: a systematic review and meta-analysis. Eur J Dermatol 28:750–763
Muller SA, Winkelmann RK (1963) Alopecia Areata: an evaluation of 736 cases. Arch Dermatol 88:290–297
Cunliffe WJ, Hall R, Stevenson CJ, Weightman D (1969) Alopecia areata, thyroid diseases and autoimmunity. Brit J Dermatol 81:879–881
Milgraum SS, Mtchell AJ, Bacon GE, Rasmussen JE (1987) Alopecia areata, endocrine function, and autoantibodies in patients 16 years of age or younger. J Am Acad Dermatol 17:57–61
Nanda A, Alsaleh QA, Al-Hasawi F, Al-Muzairai I (2002) Thyroid function, autoantibodies, and HLA tissue typing in children with alopecia areata. Pediatric Dermatol 19:486–491
Kakourou T, Karachristou K, Chrousos G (2006) A case series of alopecia areata in children: impact of personal and family history of stress and autoimmunity. J Eur Acad Dermatol Venereol 21:356–359
Betterle C, Peserico A, Del Prete GF, Trisotto A (1975) Autoantibodies in alopecia areata. Arch Dermatol 111:927–928
Pauvilai S, Pauvilai G, Charuwichitratana S, Sakuntabhai A, Sriprachya-Anunt S (1994) Prevalence of thyroid diseases in patients with alopecia areata. Int J Dermatol 33:632–633
Tan E, Tay YK, Goh CL, Giam YC (2002) The pattern and profile of alopecia areata in Singapore-a study of 219 Asians. Int J Dermatol 41:748–753
Betterle C, Cipriani R, Pedini B, Peserico A (1984) Alopecia areata: a heterogeneous disease? Lancet 2:635
Thomas EA, Kadyan RS (2008) Alopecia areata and autoimmunity: a clinical study. Indian J Dermatol 53:70–74
Han TY, Lee JH, Noh TK et al (2018) Alopecia areata and overt thyroid diseases: a nationwide population-based study. J Dermatol 45:1411–1417
Lee S, Lee H, Lee CH, Lee WS (2019) Comorbidities in alopecia areata: a systematic review and meta analysis. J Am Acad Dermatol 80:466-477.e16
Crosby DL, Diaz LA (1993) Autoimmune diseases of the skin. In: Autoimmune diseases. Immunol Allergy Clin N Am 13:395–419
Pitoia F, Moncet D, Glorio R et al (2005) Prevalence of thyroid autoimmunity in patients with pemphigus vulgaris. Medicina (B Aires) 65:307–310
Ameri P, Cinotti E, Mussap M, Murialdo G, Parodi A, Cozzani E (2013) Association of pemphigus and bullous pemphigoid with thyroid autoimmunity in Caucasian patients. J Am Acad Dermatol 68:687–689
Kridin K, Khamaisi M, Comaneshter D, Batat E, Cohen AD (2018) Autoimmune thyroid diseases and thyroid cancer in pemphigus: a big data analysis. Front Med (Lausanne) 5:159
Fiorucci MC, Cozzani E, Casu M, Murialdo G, Parodi A, Rebora A (2005) Bullous pemphigoid and Graves’ disease: an association between skin and thyroid autoimmunity. Acta Derm Venereol 85:560–561
Tirado-Sánchez A, Montes-de-Oca G (2005) Coexistence of bullous pemphigoid, vitiligo, and thyroid disease: a multiple autoimmune syndrome? Dermatol Online J 11:20
Lee J, Seiffert-Sinha K, Attwood K et al (2019) A retrospective study of patient-reported data of bullous pemphigoid and mucous membrane pemphigoid from a US-based registry. Front Immunol 10:2219
Wu PC, Wu CY, Lyu YS, Chang YT, Wu CY (2022) Lack of association between bullous pemphigoid and autoimmune thyroid disease: a population-based case-control study. J Dtsch Dermatol Ges 20:511–513
Kridin K, Hübner F, Linder R, Schmidt E (2022) The association of six autoimmune bullous diseases with thyroid disorders: A population-based study. J Eur Acad Dermatol Venereol. https://doi.org/10.1111/jdv.18266
Cunningham MJ, Zone JJ (1985) Thyroid abnormalities in dermatitis herpetiformis. Ann Int Med 102:194–196
Weetman AP, Burrin JM, Mckay D, Leonard JN, Griffiths CE, Fry L (1988) The prevalence of thyroid autoantibodies in dermatitis herpetiformis. Br J Dermatol 118:377–383
Gaspari AA, Huang CM, Davey RJ, Bondy C, Lawley TJ, Katz SI (1990) Prevalence of thyroid abnormalities in patients with dermatitis herpetiformis and in control subjects with HLA-B8/-DR3. Am J Med 88:145–150
Zettinig G, Weissel M, Flores J, Dudczak R, Vogelsang H (2000) Dermatitis herpetiformis is associated with atrophic but not with goitrous variant of Hashimoto’s thyroiditis. Eur J Clin Invest 30:53–57
Sabroe RA, Greaves MW (1997) The pathogenesis of chronic idiopatic urticaria. Rch Dermatol 1333:1003–1008
Gruber BL, Baeza M, Marchese M, Agnella V, Kaplan AP (1988) Prevalence and functional role of anti-IgE autoantibodies in urticarial syndromes. J Invest Dermatol 90:213–217
Hide M, Francis DM, Grattan CEH, Hakimi J, Kochan JP, Greaves MW (1993) Autoantibodies to high-affinity IgE receptor as a causee of histamine release in chronic urticaria. N Engl J Med 328:1599–1604
Greaves MW (1995) Chronic urticaria. N Engl J Med 332:1767–1772
Pan XF, Gu JQ, Shan ZY (2015) The prevalence of thyroid autoimmunity in patients with urticaria: a systematic review and meta-analysis. Endocrine 48:804–810
Gonzalez-Diaz SN, Sanchez-Borges M, Rangel-Gonzalez DM, Guzman-Avilan RI, Canseco-Villarreal JI, Arias-Cruz A (2020) Chronic urticaria and thyroid pathology. World Allergy Organ J 13:100101. https://doi.org/10.1016/j.waojou.2020.100101
Conti-Fine BM, Milani M, Kaminski HJ (2006) Myasthenia gravis: past, present and future. J Clin Invest 116:2843–2854
Phillips WD, Vincent A (2016) Pathogenesis of myasthenia gravis: update on disease types, models, and mechanisms. F1000Res 5:F1000. https://doi.org/10.12688/f1000research.8206.1. (Faculty Rev-1513)
Kiessling WR, Finke R, Kotulla P, Schleusener H (1982) Circulating TSH-binding inhibiting immunoglobulins in myasthenia gravis. Acta Endocrinol 101:41–46
Monden Y, Uyama T, Nakahara K et al (1986) Clinical characteristics and prognosis of myasthenia gravis with other autoimmune diseases. Ann Thorac Surg 41:189–192
Marinò M, Ricciardi R, Pinchera A et al (1997) Mild clinical expression of myasthenia gravis associated with autoimmune thyroid disaeses. J Clin Endocrinol Metab 82:438–443
Weissel M (1997) Mild clinical expression of myasthenia gravis associated with autoimmune thyroid disaese. J Clin Endocrinol Metab 82:3905–3906
Aarli JA, Thunold S, Heimann P (1978) Thyroiditis in myasthenia gravis. Acta Neurol Scand 58:121–127
Scherbaum WA, Schumm F, Maish B (1983) Myasthenia gravis: overlap with “polyendocrine” autoimmunity. Klin Wochenschr 61:509–515
Thorlacious S, Aarli JA, Riise T, Matre R, Johnses HJ (1989) Associated disorders in myasthenia gravis: autoimmune diseases and their relation to thymectomy. Acta Neurol Scand 80:290–295
Aarli JA, Gilhus NE, Matre R (1992) Myasthenia gravis with thymoma is not associated with increased incidence of non muscle autoimmune disorders. Autoimmunity 11:159–162
Tola MR, Caniatti LM, Casetta I, Granieri E, Conighi C, Quatrale R et al (1994) Immunogenetic heterogeneity and associated autoimmune disorders in myasthenia gravis: a population-based survey in the province of Ferrara, northern Italy. Acta Neurol Scand 90:318–323
Christensen PB, Jensen TS, Tsiropoulos I et al (1995) Associated autoimmune diseases in myasthenia gravis. A population-based study. Acta Neurol Scand 91:192–195
Weissel M, Mayr N, Zeitlhofer J (2000) Clinical significance of autoimmune thyroid diseases in myasthenia gravis. Exp Clin Endocrinol Diabetes 108:63–65
Song RH, Yao QM, Wang B, Li Q, Jia X, Zhang JA (2019) Thyroid disorders in patients with myasthenia gravis: a systematic review and meta-analysis. Autoimmun Rev 18:102368
Lennon VA, Lambert EH, Whittingham S, Fairbanks V (1982) Autoimmunity in the Lambert-Eaton myasthenic syndrome. Muscle Nerve 5(9S):S21-25
Wirtz PW, Bradshaw J, Wintzen AR, Verschuuren JJ (2004) Associated autoimmune diseases in patients with the Lambert-Eaton myasthenic syndrome and their families. J Neurol 251:1255–1259
Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG (2000) Multiple sclerosis. N Engl J Med 343:938–952
Kiessling WR, Pflughaupt KW (1980) Antithyroid antibodies in multiple sclerosis. Lancet 1(8158):41
De Keyser J (1988) Autoimmunity in multiple sclerosis. Neurology 38:371–374
Seyfert S, Klapps P, Meisel C, Fisher T, Junghan U (1990) Multiple sclerosis and other immunologic diseases. Acta Neurol Scand 81:37–42
Ioppoli C, Meucci G, Mariotti S et al (1990) Circulating thyroid and gastric parietal cell autoantibodies in patients with multiple sclerosis. It J Neurol Sci 11:31–36
Annunziata P, Lorè F, Venturini E et al (1999) Early synthesis and correlation of serum anti-thyroid antibodies with clinical parameters in multiple sclerosis. J Neurol Sci 168:32–36
Karni A, Abramsky O (1999) Association of MS with thyroid disorders. Neurology 53:883–885
Sakuma R, Fujihara K, Sato N, Mochizuki H, Itoyama Y (1999) Optic-spinal form of multiple sclerosis and anti-thyroid autoantibodies. J Neurol 246:449–453
Durelli L, Oggero A, Verdun E, Betaferon Safety Trial (BEST) Study Group et al (2001) Thyroid function and anti-thyroid antibodies in MS patients screened for interferon treatment. A multicenter study. J Neurol Sci 193:17–22
Vecino MC, Czepielewski M, Freitas DMO et al (2004) Prevalencia de anticorpos antimicrossomais em pacientes com esclerose multipla. Arq Neurosiquiatr 62:674–677
Sloka JS, Phillips PW, Stefanelli M, Joyce C (2005) Co-occurrence of autoimmune thyroid diseases in a multiple sclerosis cohort. J Autoim Dis 2:9
Caraccio N, Dardano A, Manfredonia F et al (2005) Long-term follow-up of 106 multiple sclerosis patients undergoing interferon-γ 1a or 1b therapy: predictive factors of thyroid disease development and duration. J Clin Endocrinol Metab 90:4133–4137
Niederwieser G, Buchinger W, Bonelli RM et al (2003) Prevalence of autoimmune thyroiditis and non-immune thyroid disease in multiple sclerosis. J Neurol 250:672–675
Muller I, Moran C, Lecumberri B et al (2019) European thyroid association guidelines on the management of thyroid dysfunction following immune reconstitution therapy. Eur Thyroid J 8:173–185
Rotondi M, Molteni M, Leporati P, Capelli V, Marinò M, Chiovato L (2017) Autoimmune thyroid diseases in patients treated with alemtuzumab for multiple sclerosis: an example of selective anti-TSH-receptor immune response. Front Endocrinol (Lausanne) 8:254
Alamo A, Condorelli RA, La Vignera S, Calogero AE (2019) Autoimmune thyroid disease following treatment with alemtuzumab for multiple sclerosis. Int J Immunopathol Pharmacol 33:2058738419843690
Jarius S, Wildemann B, Paul F (2014) Neuromyelitis optica: clinical features, immunopathogenesis and treatment. Clin Exp Immunol 176:149–164
Wang X, Yi H, Liu J et al (2016) Anti-thyroid antibodies and thyroid function in neuromyelitis optica spectrum disorders. J Neurol Sci 366:3–7
Pereira WLCJ, Reiche EMV, Kallaur AP et al (2017) Frequency of autoimmune disorders and autoantibodies in patients with neuromyelitis optica. Acta Neuropsychiatr 29:170–178
Shahmohammadi S, Doosti R, Shahmohammadi A et al (2019) Autoimmune diseases associated with neuromyelitis optica spectrum disorders: a literature review. Mult Scler Relat Disord 27:350–363
Huo L, Wang H, Yuan Y, Gao J, Liu X (2022) Positive antithyroid antibody predict severity of neuromyelitis optica spectrum disorder in children. Mult Scler Relat Disord 57:103425
Solimena M, Folli F, Aparisi R, Pozza G, De Camilli P (1990) Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome. N Engl J Med 322:1555–1560
Grimaldi LM, Martino G, Braghi S et al (1993) Heterogeneity of autoantibodies in stiff-man syndrome. Ann Neurol 34:57–64
Chia SY, Chua R, Lo YL, Wong MC, Chan LL, Tan EK (2007) Acute ataxia, Graves’ disease, and stiff person syndrome. Mov Disord 22:1969–1971
Medeiros LM, Morais TC, Primo AEL, Speltri VC, Rocha MSG (2016) Stiff-person syndrome and Graves’ disease: a pediatric case report. Child Neurol Open 3:2329048X16684397
Nie DA, Abud A, Serrano-Gonzalez M, Harappanahally G, Patil R (2022) Pediatric stiff limb syndrome with polyautoimmunity of anti-GAD-65, anti-islet cell, and thyroid peroxidase antibodies: a case report and review of literature. Neuroimmunol 367:577865
Muranova A, Shanina E (2022) Stiff Person Syndrome. [Updated 2022 Jul 18]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. https://www.ncbi.nlm.nih.gov/books/NBK573078/
Behar R, Penny R, Powell HC (1986) Guillain-Barré syndrome associated with Hashimoto’s thyroiditis. J Neurol 133:133–236
Pandolfi C, Filippi C (1989) Guillain-Barré syndrome associated with hypothyroidism. Report of a case. Minerva Med 80:1129–1131
Shoenfeld Y, George J, Peter JB (1996) Guillain-Barré as an autoimmune disease. Int Arch Allergy Immunol 109:318–326
Polizzi A, Ruggieri M, Vecchio I, Genovese S, Rampello L, Raffaele R (2001) Autoimmune thyroiditis and acquired demyelinating polyradiculoneuropathy. Clin Neurol Neurosurg 103:151–154
Kohli RS, Bleibel W, Bleibel H (2007) Concurrent immune thrombocytopenic purpura and Guillain-Barre syndrome in a patients with Hashimoto’s thyroiditis. Am J Hematol 82:307–308
Toudou Daouda M, Obenda NS, Maazou L, Camara D, Souirti Z, Elmidaoui A (2016) Guillain-Barre syndrome and Hashimoto’s thyroiditis. QJM 109:547–548
Pattan V, Chiu KC, Samoa R (2021) Recurrent, refractory hypokalemia as a diagnostic clue to thyrotoxic periodic paralysis in a patient with acute kidney injury and suspected Guillain-Barrè syndrome. Clin Case Rep 9:e04443
Zang Q, Wang Y, Guo J et al (2022) Treatment of severe Japanese encephalitis complicated with Hashimoto's thyroiditis and Guillain-Barré syndrome with protein a immunoadsorption: a case report. Front Immunol 807937
Asano M, Kenzaka T (2022) Guillain-Barré syndrome with transition from Hashimoto’s to Graves’ disease: a case report. BMC Endocr Disord 22:157
Jaggarao N, Voth D, Jacobsen J (1989) The Vogt-Koyanagi-Harada syndrome: association with hypothyroidism and diabetes mellitus. Postgrad Med J 65:587–588
Chi HI, Furue M, Ishibashi Y (1994) Vogt-Koyanagi-Harada’s syndrome associated to Hashimoto’s thyroiditis. J Dermatol 21:683–686
Jovic NS, Nesovic M, Vranjesevic DN, Ciric J, Marinkovic DM, Bonaci B (1996) The Voght-Koyanagi-Harada syndrome: association with autoimmune polyglandular syndrome type 1. Postgrad Med J 72:495–497
Paroli MP, Pinca M, Speranza S, Marino M, Pivetti-Pezzi P (2003) Paracentral corneal melting in a patient with Vogt-Koyanagi-Harada’s syndrome, psoriasis, and Hashimoto’s thyroiditis. Ocul Immunol Inflamm 11:309–313
Wasastjerna C (1959) Two auto-immune diseases in one patient: a case of hemolytic anemia and Hashimoto’s thyroiditis. Acta Med Scand 18(165):299–304
Girelli G, Lio S, Adorno G, Perrone MP, D’Armiento M (1986) Thyroid functioning in autoimmune hemolytic anemias. Scand J Haematol 37:266
Naji P, Kumar G, Dewani S, Diedrich WA, Gupta A (2013) Graves’ disease causing pancytopenia and autoimmune hemolytic anemia at different time intervals: a case report and a review of the literature. Case Rep Med. https://doi.org/10.1155/2013/194542
Moore JA, Gliga L, Nagalla S (2017) Thyroid storm and warm autoimmune hemolyticanemia. Transfus Apher Sci 56:606–608
Sugisaki M, Ishizaki T, Iriuchishima H et al (2019) Thyroid storm and exacerbation of autoimmune hemolytic anemia following childbirth. Rinsho Ketsueki 60:924–928
Branehog I, Olsson KS, Weinfeld A, Domellof I (1979) Association of hyperthyroidism with idiopathic thrombocytopenic purpura and hemolytic anaemia. Acta Med Scand 205:125–131
Lee FY, Ho CH, Chong LL (1985) Hyperthyroidism and Evan’s syndrome: a case report. Taiwan I Hsueh Hui Tas Chih 84:256–260
Ysashiro M, Nagoshi H, Kasuga Y et al (1996) Evan’s syndrome associated to Graves’ disease. Inter Med 35:987–990
Ikeda K, Maruyama Y, Yokoyama M et al (2001) Association of Graves’ disease with Evan’s syndrome in a patient with IgA nephropathy. Intern Med 40:1004–1010
Kuroda H, Kida M, Watanabe H, Matsunaga T, Niitsu Y, Matsumoto M (2005) Basedow disease associated with Evan’s syndrome. Rinsho Ketsueki 46:1118–1122
Rivalta B, Zama D, Pancaldi G, Facchini E et al (2019) Evan’s syndrome in childhood: long term follow-up and the evolution in primary immunodeficiency or rheumatological disease. Front Pediatr 7:304
Shimomura H, Nakase Y, Furuta H et al (2003) A rare case of autoimmune polyglandular syndrome type 3. Diabetes Res Clin Pract 61:103–108
Litao MKS, Alvarez AG, Shah B (2021) Pre-treatment neutropenia in children and adolescents with autoimmune hyperthyroidism. J Clin Res Pediatr Endocrinol 13:263–268
Marshall JS, Weisberger AS, Levy RP, Breckenride RT (1967) Coexistent idiopathic thrombocytopenic purpura and hyperthyroidism. Ann Intern Med 67:411–414
Herman J, Resnitzky P, Fink A (1978) Association between thyrotoxicosis and thrombocytopenia. Isr J Med Sci 14:469–475
Valenta LJ, Treadwell T, Berry R, Elias N (1982) Idiopathic thrombocytopenic purpura and Graves’ disease. Am J Hematol 12:69–72
Pratt EL, Tarantino MD, Wagner D et al (2005) Prevalence of elevated antithyroid antibodies and antinuclear antibodies in children with immune thrombocytopenic purpura. Am J Hematol 79:175–179
Cordiano I, Betterle C, Spadaccino A, Soini B, Girolami A, Fabris F (1998) Autoimmune thrombocytopenia (AITP) and thyroid autoimmune disease (TAD): overlapping syndrome? Clin Exp Immunol 113:373–378
Ito S, Fujiwara SI, Murahashi R, Nakashima H et al (2021) Clinical association between thyroid disease and immune thrombocytopenia. Ann Hematol 100:345–352
Becker KL, Ferguson RH, Mc Conahey WM (1963) The connective tissue diseases and symptoms associated with Hashimoto’s thyroiditis. N Engl J Med 268:277–280
Masi AT, Hartmann WH, Hahn BH, Hahn B, Abbey H, Shulman LE (1965) Hashimoto’s disease. A clinicopathological study with matched controls. Lack of significant associations with other autoimmune disorders. Lancet 1:123–126
White RG, Bass BH, Williams E (1961) Lymphadenoid goitre and the syndrome of systemic lupus erythematosus. Lancet 1:368–373
Loviselli A, Velluzzi F, Pala R et al (1992) Circulating antibodies to DNA-related antigens in patients with autoimmune thyroid disorders. Autoimmunity 14:33–36
Morita S, Arima T, Matsura M (1995) Prevalence of nonthyroid specific autoantibodies in autoimmune thyroid diseases. J Clin Endocrinol Metab 80:1203–1206
Kumar K, Kole AK, Karmakar PS, Ghosh A (2012) The spectrum of thyroid disorders in systemic lupus erythematosus. Rheumatol Int 32:73–78
Pan XF, Gu JQ, Shan ZY (2015) Patients with systemic lupus erythematosus have higher prevalence of thyroid autoantibodies: a systematic review and meta-analysis. PLoS ONE 10:e0123291
Ferrari SM, Elia G, Virili C, Centanni M, Antonelli A, Fallahi P (2017) Systemic lupus erythematosus and thyroid autoimmunity. Front Endocrinol (Lausanne) 8:138
Luo W, Mao P, Zhang L, Yang Z (2018) Association between systemic lupuserythematosus and thyroid dysfunction: a meta-analysis. Lupus 27:2120–2128
Konstadoulakis MM, Kroubouzos G, Tosca A et al (1993) Thyroid autoantibodies in the subsets of lupus erythematosus: correlation with other autoantibodies and thyroid function. Thyroidology 5:1–7
Koskenmies S, Järvinen TM, Onkamo P (2008) Clinical and laboratory characteristics of Finnish lupus erythematosus patients with cutaneous manifestations. Lupus 17:337–347
van deer Meer-Roosen CH, Maes EP, Faber WR (1979) Cutaneous lupus erythematosus and autoimmune thyroiditis. Br J Dermatol 101:91–92
Callen JP (1984) Discoid lupus erythematosus in a patient with vitiligo and autoimmune thyroiditis. Int J Dermatol 23:203–204
Sharma S, Sarkar R, Garg VK, Bansal S (2013) Coexistence of lip-tip vitiligo and disseminated discoid lupus erythematosus with hypothyroidism: need for careful therapeutic approach. Indian Dermatol Online J 4:112–114
George RT, Murthy SC, Raghuveer C, Degulamadi VH (2022) Colocalisation of subacute cutaneous lupus erythematosus and vitiligo in a woman with thyroid autoantibodies: an intriguing association. Indian J Dermatol Venereol Leprol 88:219–221
Mulhern IM, Masi AT, Shulman LE (1966) Hashimoto’s disease: a search for associated disorders in 170 clinically detected cases. Lancet 2:508–511
Thomas DJ, Young A, Gorsuch AN, Bottazzo GF, Cudworth AG (1983) Evidence for an association between rheumatoid arthritis and autoimmune endocrine diseases. Ann Rheum Dis 42:297–300
Gordon T, Isenberg D (1987) The endocrinologic associations of the autoimmune rheumatic diseases. Sem In Arth Rheum 17:58–70
Shiroky JB, Cohen M, Ballachey ML, Neville C (1993) Thyroid dysfunction in rheumatoid arthritis: a controlled prospective study. Ann Rheum Dis 52:454–456
Bianchi GP, Marchesini G, Zoli M et al (1993) Thyroid involvement in chronic inflammatory rheumatological disorders. Clin Rheumatol 12:479–484
Andonopoulos AP, Siambi V, Makri M, Christofidou M, Markou C, Vagenkis AG (1996) Thyroid function and immune profile in rheumatoid arthritis. A controlled study. Clin Rheumatol 15:599–603
Mihailova D, Grigorova R, Vassileva B et al (1999) Autoimmune thyroid diosrders in juvenile chronic arthritis and systemic lupus erythematosus. Adv Exp Med Biol 455:55–60
Punzi L, Betterle C (2004) Chronic autoimmune thyroiditis and rheumatic manifestations. Joint Bone Spine 71:275–283
Robazzi TC, Adan LF, Pimentel K et al (2013) Autoimmune endocrine disorders and coeliac disease in children and adolescents with juvenile idiopathic arthritis and rheumatic fever. Clin Exp Rheumatol 31:310–317
Hu Y, Wang H, Deng J (2014) Adult-onset Still’s disease associated with thyroid dysfunction: case report and review of the literature. Open Rheumatol J 8:9–12
Alhomaidah D, Alsagheir A, Al-Mayouf SM (2016) Coexistence of endocrinopathies in children with rheumatic diseases. Int J Pediatr Adolesc Med 3:119–122
Hämeenkorpi R, Hakala M, Ruuska P, Mäkitalo R, Tiilikainen A, Forsberg S (1993) Thyroid disorder in patients with mixed connective tissue disease. J Rheumatol 20:602–603
Tomsic M, Hojker S, Zaletel-Kragelj L, Rozman B (1995) Prevalence of autoimmune thyroid disease (AITD) in patients with mixed connective tissue disease (MCTD). Clin Rheumatol 14:379–380
Bloch KJ, Buchanan WW, Wohl MJ, Bunin JJ (1965) Sjogren syndrome. A clinical, pathological and sierological study of 62 cases. Medicine (Baltimore) 44:187–231
Hughes GRV, Whaley K (1972) Sjogren’s syndrome. Br Med J 2:533–536
Karsh J, Pavlidis N, Weintraub BD, Moutsopoulos HM (1980) Thyroid disease in Sjogren’s syndrome. Arthritis Rheum 21:1326–1329
Fox RI, Howell FV, Bone RC, Michelson P (1984) Primary Sjogren’s syndrome. Clinical and immunopathologig features. Seminar Arth Rheum 14:77–105
Pérez B, Kraus A, Lopez G, Cifuentes M, Alarcon-Segovia D (1995) Autoimmune thyroid disese in primary Sjogren’s syndrome. Am J Med 99:480–484
Punzi L, Ostuni PA, Betterle C, De Sndre P, Botsios C, Gambari F (1996) Thyroid gland disorders in primary Sjogren’s syndrome. Rev Rheum 63:809–814
Sun X, Lu L, Li Y, Yang R, Shan L, Wang Y (2019) Increased risk of thyroid disease in patients with Sjogren’s syndrome: a systematic review and meta-analysis. Peer J 7:e6737
Girón-Pïllado M, Cruz-Bautista I, Saavedra-González V et al (2022) Autoimmune thyroid disease in primary sjögren’s syndrome: real-life screening practice and clinical outcomes. Curr Rheumatol Rev. https://doi.org/10.2174/1573397118666220127105546
Hansen U, Ericsson UB, Larsson A, Manthorpe R, Warfvinge G (1991) Autoimmune thyroiditis and primary Sjögren syndrome: clinical and laboratory evidence of the coexistence of the two diseases. Clin Exp Rheumatol 9:137–141
Coll J, Anglada J, Tomas S et al (1997) High prevalence of subclinical Sjogren’s syndrome features in patients with autoimmune thyroid disease. J Rheumatol 24:1719–1724
Lukjanowicz M, Bobrowska-Snarska D, Brzosko M (2006) Coexistence of hypothyroidism with polymyositis or dermatomyositis. Ann Acad Med Stetin 52(Suppl 2):49–55
Yao HH, Li YH, Zhang XW, Li ZG (2011) Clinical analysis and immunologicalcharacteristics of patients with dermatomyositis and thyroid dysfunction. Beijing Da Xue Xue Bao Yi Xue Ban 43:209–212
Chen P, Xie J, Xiao R, Zhang G, Qiu X, Zhan Y (2019) Clinical analysis for 108 cases of dermatomyositis. Zhong Nan Da Xue Xue Bao Yi Xue Ban 44:1157–1162
Yao Q, Song Z, Wang B, Zhang JA, Mu K (2019) Thyroid disorders in patients with systemic sclerosis: A systematic review and meta-analysis. Autoimmun Rev 18:634–636
Rovenský J, Sedlácková M (2012) Relabujúca polychondritída [Relapsing polychondritis]. Cas Lek Cesk 151:64–68
Takamatsu K, Nishiyama T, Nakauchi Y, Yamano T, Ohno F (1989) A cases of insulin-dependent diabetes mellitus associated with relapsing polychondritis, Hashimoto’s thyroiditis and pituitary adrenocortical insufficiency in succession. Jpn J Med 28:232–236
Amsalhem P, Gaudouen Y, Krivitzky A (2001) Atrophic polychondritis and Hashimoto’s thyroiditis: apropos of a case. Rev Med Interne 2:890–891
Nakajima T, Yoshifuji H, Yamano Y et al (2022) Co-occurrence of relapsing polychondritis and autoimmune thyroid diseases. Orphanet J Rare Dis 17:101. https://doi.org/10.1186/s13023-022-02261-5
Cebeci F, Onsun N, Pekdemir A, Uras AR, Kayataş K (2013) Thyroid autoimmunity and Behçet's disease: is there a significant association? SciWorld J 956837
Lin HP, Wu YH, Yu-Fong Chang J, Wang YP, Chen HM, Sun A (2018) Gastric parietal cell and thyroid autoantibodies in patients with Behcet’s disease. J Formos Med Assoc 117:505–511
Caforio AL, Tona F, Bottaro S et al (2008) Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy. Autoimmunity 41:35–45
Fatourechi V, Edwards WD (2000) Graves’ disease and low-output cardiac dysfunction: implication for autoimmune disease in endomyocardial biopsy tissue from eleven patient. Thyroid 10:601–605
Yagoro A, Tada H, Hidaka Y et al (1999) Postpartum onset of acute heart failure due to postpartum autoimmune myocarditis. A report of three case. J Intern Med 245:199–203
Schumann C, Faust M, Gerharz M, Ortmann M, Schubert M, Krone W (2005) Autoimmune polyglandular syndrome associated with idiopathic giant cell myocarditis. Exp Clin Endocrinol Diabetes 113:302–307
Steinberg L (2021) Congenital heart block. Card Electrophysiol Clin 13:691–702
Fairfax AJ, Leatham A (1975) Idiopathic heart block: association with vitiligo, thyroid disease, pernicious anaemia, and diabetes mellitus. Br Med J 4:322–324
Ertugrul DT, Yavuz B, Yalcin AA et al (2008) Hashimoto’s thyroiditis is a frequent occurrence in patients with rheumatic mitral stenosis. J Heart Valve Dis 17:635–638
Robazzi TC, Adan LF (2012) Autoimmune thyroid disease in patients with rheumatic diseases. Rev Bras Reumatol 52:417–430
Edwards CJ, Hughes GRV (2008) Hughes syndrome (the antiphospholipid syndrome): 25 years old. Mod Rheumatol 18:119–124
Selenkow HA, Cline MJ, Fudenberg H (1961) Thyroid autoantibodies and a biological false-positive reaction to the test for syphilis. Am J Med 31:144–148
Marongiu F, Cont M, Murtas ML et al (1991) Anticardiolipin antibodies in Graves’ disease: relationship with thrombin activity in vivo. Thromb Res 64:745–749
Petri M, Karlson EW, Cooper DS, Ladenson PW (1991) Autoantibody tests in autoimmune thyroid disease: a case control study. J Rheumatol 18:1529–1531
Carré Y, Canivet B, Roul C et al (1993) Circulating anticoagulant and antiplatelet immunoglobulin in autoimmune thyroid disease. Eur J Med 2:121–122
Paggi A, Caccavo D, Ferri GM et al (1994) Anti-cardiolipin antibodies in autoimmune thyroid diseases. Clin Endocrinol 40:329–333
Nabriski D, Ellis M, Ness-Abramof SM, Shenkman L (2000) Autoimmune thyroid disease and antiphospholipid antibodies. Am J Hematol 64:73–75
Stagnaro-Green A, Abalovich M, Alexander E et al (2011) American Thyroid Association Taskforce on Thyroid Disease During Pregnancy and Postpartum. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid 21:1081–1125
Versini M (2017) Thyroid autoimmunity and antiphospholipid syndrome: not such a trivial association. Front Endocrinol (Lausanne) 8:175
Jenette JC, Falk RJ (1997) Small-vessel vasculitis. N Engl J Med 337:1512–1523
Lionaki S, Hogan SL, Falk RJ et al (2007) Association between thyroid disease and its treatment with ANCA small-vessel vasculitis: a case-control study. Nephrol Dial Transpl 22:3508–3515
Balavoine AS, Glinoer D, Dubucquoi S, Wémeau JL (2015) Antineutrophil cytoplasmic antibody-positive small-vessel vasculitis associated with antithyroid drug therapy: how significant is the clinical problem? Thyroid 25:1273–1281
Thomas RD, Croft DN (1974) Thyrotoxicosis and giant-cell arteritis. Brit Med J 2:408–409
Wiseman P, Stewart K, Rai GS (1989) Hypothyroidism in polymyalgia rheumatica and giant cell arteritis. BMJ 298(6674):647–648
Barrier JH, Abram M, Brisseau JM, Planchon B, Grolleau JY (1992) Autoimmune thyroid disease, thyroid antibodies and giant cell arteritis: the supposed correlation appears fortuitous. J Rheumatol 19:1733–1734
Juchet H, Labarthe MP, Ollier S, Vilain C, Arlet P (1993) Prevalence of hypothyroidism and hyperthyroidism in temporal arteritis and rhizomelic pseudopolyarthritis. A controlled study in 104 cases. Rev Rhum Ed Fr 60:493–498
Myklebust G, Gran JT (1996) A prospective study of 287 patients with polymyalgia rheumatica and temporal arteritis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis. Br J Rheumatol 35:1161–1168
Duhaut P, Bornet H, Pinède L et al (1999) Giant cell arteritis and thyroid dysfunction: multicentre case-control study. Br Med J 318:434–435
Liozon E, Loustaud-Ratti V, Soria P et al (2005) Maladie de Horton: associations morbide in 250 maladies. La Presse Mèdicale 33:1404–1312
Dent GR, Edwards OM (1978) Autoimmune thyroid diseases and the polymyalgia rheumatica-giant cell arteritis syndrome. Clin Endocrinol 9:215–219
Antonelli A, Ferri C, Fallahi P et al (2004) Thyroid involvement in patients with overt HCV-related mixed cryoglobulinaemia. Q J Med 97:499–506
Fallahi P, Ferrari SM, Ruffilli I et al (2016) Incidence of thyroid disorders in mixed cryoglobulinemia: results from a longitudinal follow-up. Autoimmun Rev 15:747–751
Miyata M, Kumakawa H, Funabashi Y et al (1994) Henoch-Schonlein purpura associated with pregnancy in a patient with chronic thyroiditis. Fukushima J Med Sci 40:45–49
Shin J, Park MJ, Kim DH et al (2006) Association of Henoch-Schonlein purpura and Graves’ disease. Nephrol Dial Transpl 21:2997
Wang XL, Wang YX, Liu M, Cheng Y, He XJ, Zhang YL (2020) Twin sisters with Hashimoto’s thyroiditis and Henoch-Schönlein purpura. Endokrynol Pol 71:573–574
Sanjari M, Shakibi M, Safavi M (2021) Henoch-Schönlein Purpura (IgA Vasculitis) in association with thyrotoxicosis. Case Rep Endocrinol. https://doi.org/10.1155/2021/6669653
Ito H, Fukuda K, Ashida K et al (2022) Case report: myxedema coma caused by immunoglobulin a vasculitis in a patient with severe hypothyroidism. Front Immunol 13:838739
Boutin J, Cornec A, Chevrant-Breton J, Almange C, Guérin D (1978) Hyparacute periarteritis nodosa complicating Basedow’s disease. Sem Hop 54:1430–1432
Guillevin L, Krivitzky A, Rouby JJ, Bletry O, Langlois P, Godeau P (1980) Fatal polyarteritis nodosa following Graves’ disease. Sem Hop 56:1877–1878
Schneider I, Palyi I, Dobos J (1981) Cutaneous benign polyarteritis nodosa. Simultaneous occurrence with autoimmune hyperthyreosis. Dermatol Manatsschr 167:418–424
Okayama Y, Mori M, Onai T et al (1987) A case of polyarteritis nodosa associated with primary hypothyroidism. Nippon Naika Gakkai Zasshi 76:742–743
Inada C, Yoshida H, Sumino M et al (2000) A case of microscopic polyarteritis nodosa associated with autoimmune hepatitis complicated with rheumatoid arthritis and chronic thyroiditis. Nihon Shokakibyo Gakkai Zasshi 97:925–929
Armbruster C, Vetter N (1991) Wegener’s granulomatosis with splenic involvement and Hashimoto’s lymphomatous thyroiditis. Pneumologie 45:28–23
Masor JJ, Gal AA, LiVolsi VA (1994) Case report: Hahimoto’s thyroiditis associated with Wegener’s granulomatosis. Am J Med Sci 308:112–114
Kagioka H, Kinoshita S, Koga T et al (1999) Case of Wegener’s granuloma complicated with chronic thyroiditis and myelopathy and developing epidural lipomatosis during treatment. Nippon Naika Gakkai Zasshi 88:2020–2021
Rosmarakis ES, Kapaskelis AM, Rafailidis PI, Falagas ME (2005) Association between Wegener’s granulomatosis and increased antithyroid antibodies: report of two cases and review of the literature. Int J Clin Pract 59:373–375
Khalifa M, BenFredj H, Ghannouchi N, Sriha B, Letaief A, Bahri F (2009) Atteinte thyroïdienne au cours de la granulomatose de Wegener: à propos d’un cas. Rev Med Interne 30:176–178
Shimokawa H, Koiwaya Y, Kaku T (1983) Annuloaortic ectasia in a case of Takayasu’s arteritis associated with Hashimoto’s disease. Heart 49:94–97
Odaka H, Kiso K, Watanabe K, Obata A, Miyamuma H, Muryoi T (2002) Case of Takayasu’s arteritis (type V) together with Sjogren’s syndrome and Basedow’s disease. Nippon Naika Gakkai Zasshi 91:2768–2770
Kettaneh A, Prevot S, Biaggi A et al (2003) Hyperthyroidism in two patients with Crohn disease and Takayasu arteritis. Scand J Gastroenterol 38:901–903
Bulum J, Car N, Smircic-Duvnjak L, Gracin S, Metelko Z (2005) Takayasu’s arteritis and chronic autoimmune thyroiditis in a patient with type 1 diabetes mellitus. Clin Rheumatol 24:169–171
Shih G, Shih WJ, Huang WS, Milan PP (2008) Hashimoto thyroiditis and Takayasu aortitis: visualization of the thyroid gland and ring appearance of the mediastinum on F-18-FDG PET. Clin Nucl Med 33:377–379
Adler S, Lahmer T, Heemann U, Förger F (2009) Combined Takayasu arteritis and Hashimoto thyroiditis during 3 consecutive pregnancies. J Rheumatol 36:1555–1557
Xu AJ, Tang L (2013) Takayasu arteritis with Hashimotos Thyroiditis. Indian Pediatr 50:522–523
Park HW, Lee HS, Hwang S, Lee HS, Bae HI, Yoon G (2017) Coexistence of ulcerative colitis and Sjögren’s syndrome in a patient with Takayasu’s arteritis and Hashimoto’s thyroiditis. Intest Res 15:255–259
Barzo P, Molnar L, Minik K (1988) Churg-Strauss syndrome following autoimmune thyroiditis associated with Basedow’s disease. Orv Hetil 129:1927–1930
Keren G, Lehr V, Boichis H (1985) Erythema nodosum related to propylthiouracil treatment for thyrotoxicosis. Isr J Med Sci 21:62–63
Noto H, Iimura M, Karibe T et al (2006) A case of turner syndrome complicated with Crohn’s disease, erythema nodosum and Hashimoto disease. Nihon Shokakibyo Gakkai Zasshi 103:1039–1043
Yeh S, Li Z, Sen HN et al (2010) Scleritis and multiple systemic autoimmune manifestations in chronic natural killer cell lymphocytosis associated with elevated TCRalpha/beta+CD3+CD4-CD8- double-negative T cells. Br J Ophthalmol 94:748–752
Tanemoto M, Miyakawa H, Hanai J, Yago M, Kitaoka M, Uchida S (1995) Myeloperoxidase-antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis complicating the course of Graves’ disease: report of three adult cases. Am J Kidey Dis 26:774–780
D’Cruz D, Chesser AM, Lightowler C et al (1995) Antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis associated with anti-thyroid drug treatment. Br J Rheumatol 34:1090–1091
Kaaroud H, Khiari K, Ben Moussa F, Barbouch S, Boussema E, Ben Maïz H (2002) Une vascularite associant une atteinte rénale et pulmonaire au cours d’une maladie de Basedow traitée par le benzylthiouracile. Rev Med Interne 23:857–861
Sunder S, Venkataramanan K, Verma H, Bhardwaj M (2015) A rare case of type-I auto- immune hepatitis and thyroiditis presenting with crescentic glomerulonephritis. Saudi J Kidney Dis Transpl 26:983–986
Tian S, Xu B, Liu Z, Liu R (2020) Autoimmune polyglandular syndrome type III associated with antineutrophil cytoplasmic autoantibody-mediated crescentic glomerulonephritis: a case report and literature review. Medicine (Baltimore) 99:e19179
Korinek J, Lubanda JC, Karetova D et al (2001) Association de la maladie de Takayasu avec la thyroïdite auto-immune et la maladie coeliaque. Déroulement de la maladie et limites du traitment. J Mal Vasc 26:191–195
Elefsiniotis IS, Papatsimpas G, Liatsos GD, Tasidou A, Moulakakis A (2008) Atypical autoimmune polyglandular syndrome type 3 overlapped by chronic HCV infection resulting in carcinogenesis and fatal infection. South Med J 101:756–758
Sheehan MT, Islam R (2009) Silent thyroiditis isolated corticotropin deficiency and alopecia universalis in a patient with ulcerative colitis and elevated levels of factor VIII: an unusual case of autoimmune polyglandular syndrome type 3. Endocr Pract 15:138–142
Salzano G, Lombardo F, Arrigo T et al (2010) Association of five autoimmune diseases in a young woman with Down’s syndrome. J Endocrinol Invest 33:202–203
Betterle C, Garelli S, Coco G, Burra P (2014) A rare combination of type 3 autoimmune polyendocrine syndrome (APS-3) or multiple autoimmune syndrome (MAS-3). Auto Immun Highlights 5:27–31
Takahashi K, Anno T, Matsuda A et al (2022) Case report: onset of type 1 diabetes mellitus in patient with ulcerative colitis and Sjogren’s syndrome under euthyroid hashimoto’s thyroiditis. Front Endocrinol (Lausanne) 13:836102
Funding
No funding was received.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
On behalf of all authors, the corresponding author states that there is no conflict of interest.
Ethical approval
This is a review of the literature and no ethical approval is required.
Informed consent
Informed consent by patients was not applicable in the present paper, being a review on previous works.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Betterle, C., Furmaniak, J., Sabbadin, C. et al. Type 3 autoimmune polyglandular syndrome (APS-3) or type 3 multiple autoimmune syndrome (MAS-3): an expanding galaxy. J Endocrinol Invest 46, 643–665 (2023). https://doi.org/10.1007/s40618-022-01994-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40618-022-01994-1